GLP-1 & weight management trialsUpdated September 28, 2026

EDC built for GLP-1 and weight management clinical trials

GLP-1 receptor agonists and other anti-obesity therapies generate a distinct data profile: serial weight and body composition measurements, patient-reported GI tolerability and injection-site diaries, and safety monitoring for a well-documented adverse event pattern. Capture gives weight management trial teams one EDC, eConsent and ePRO stack for all of it, instead of a separate diary vendor bolted onto the EDC.

  • Weight & BMI calculated fields
  • GI tolerability & injection diaries
  • Structured AE capture

Free sandbox · No credit card · 21 CFR Part 11 aligned

app.capture.study · Dashboard
Capture study dashboard with enrolment, compliance, safety overview and site risk monitor

BMI

and other weight-derived fields calculate automatically, read-only during entry

10

question types for GI, appetite and injection-site diaries

1

platform for EDC, ePRO and safety reporting

0

credit card required to start

Weight & body composition

Serial weight data without a spreadsheet reconciliation

Weight management endpoints depend on clean, visit-by-visit weight and body composition data. Capture calculates BMI automatically from height and weight, read-only during entry, and applies edit checks so an implausible value raises a query the moment a site enters it.

  • BMI calculates automatically from height and weight, read-only during entry
  • Track weight, waist circumference and other body composition measures visit by visit
  • Range and custom edit checks flag an out-of-range entry immediately, not weeks later
Calculated field

BMI (Body Mass Index)

Auto-derived

Height (cm)

172

Weight (kg)

68.5

Result

23.2 kg/m²

Reference: WHO · shown read-only during data entry

AnthropometryBMIBSA (Mosteller)BSA (Du Bois)Waist-hip ratio
VitalsMAPPulse pressure
RenaleGFR (CKD-EPI 2021)CrCl (Cockcroft-Gault)
CardiacQTc (Bazett)QTc (Fridericia)QTcF from heart rate
DatesAge from DOBMinutes betweenHours between

Patient-reported tolerability

GI symptoms and injection-site reactions, reported on the participant's own schedule

GI tolerability is often the deciding factor in adherence for GLP-1 studies. Capture schedules ePRO diaries for nausea, appetite change and injection-site reactions on your protocol's cadence, with completion visible to the study team alongside CRF and safety data.

  • Scheduled diaries for GI symptoms, appetite and injection-site reactions
  • No app to install: participants complete diaries from a link on their own phone
  • Diary completion status is visible to the study team, not just the participant
Daily evening diary · Visit 1 to Visit 15
Recurring diaryDaily18:00 to 24:00Hard window
D1✓
D2✓
D3✓
D4✓
D5✓
D6Missed
D7✓
D8✓
D9✓
D10✓
D11✓
D12✓
D13Open
D14
Compliance, last 14 days92%

Safety reporting

Structured AE capture for a well-documented safety profile

GLP-1 and anti-obesity studies need consistent capture of common GI events alongside rarer, more serious ones. Capture's adverse event forms keep that structured from the first patient in.

  • Adverse event forms with onset, severity, seriousness and relationship to study drug
  • Auto-queries when a reported event or lab value breaks a configured edit check
  • One audit trail across CRF, ePRO diary and safety data
Adverse event · 01-004
AE term *Headache
Onset date *UNK-JUN-2026
Serious? *Yes
Severity / CTCAE grade *Grade 2
Causality to IMP *Required when serious
Save draftSubmit

Cannot submit yet

Causality is required because the event is serious.

Before you switch

What weight management teams check before adopting a new EDC

Cost

Free sandbox to build and test the full protocol; you pay only once you go live.

Compliance

21 CFR Part 11-aligned controls and a field-level audit trail on every record.

Setup time

Calculated BMI fields and diary templates mean less custom build from a blank form.

Migration

Bring an existing weight management protocol across from another EDC or paper.

Support

Email support, typically under 24 hours.

Build your weight management study free

Free sandbox with every feature. No credit card, no sales call.

Build your GLP-1 study free

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

Does Capture calculate BMI automatically?

Yes. BMI calculates from height and weight as a read-only field during data entry, alongside other clinical calculators such as waist-hip ratio.

Can participants report GI symptoms between visits?

Yes, through scheduled ePRO diaries that participants complete from a link on their own phone, with no app to install.

Does Capture integrate with a specific injection device or wearable?

Capture documents device usage and injection-site reactions as structured CRF and ePRO fields. It does not claim a specific device integration beyond what is confirmed for your protocol; ask us about your specific device.

How are adverse events tracked for a weight management study?

Through structured AE forms capturing onset, severity, seriousness and relationship to study drug, with edit checks that auto-raise a query on an out-of-range value.

Is this suitable for a Phase 2 obesity or metabolic study?

Yes. The same weight, diary and safety capture works for early-phase and later-phase weight management or metabolic protocols.

What does it cost to try?

Nothing to start. The free sandbox has no credit card and no time limit. You pay only once you go live with real participant data.

Build your weight management study free

Free sandbox with every feature. No credit card, no sales call.

Build your GLP-1 study free